Literature DB >> 9058802

IL-2-regulated expression of the monocyte chemotactic protein-1 receptor (CCR2) in human NK cells: characterization of a predominant 3.4-kilobase transcript containing CCR2B and CCR2A sequences.

N Polentarutti1, P Allavena, G Bianchi, G Giardina, A Basile, S Sozzani, A Mantovani, M Introna.   

Abstract

NK cells migrate in response to C-C chemokines, including monocyte chemotactic protein-1 (MCP-1) and MCP-3. Increased migration was observed in IL-2-activated NK cells. It was therefore of interest to define the expression in resting and activated NK cells of the MCP-1 receptor (CCR2) for which two cDNAs (A and B) have been described. Specific oligonucleotides and reverse-transcriptase PCR revealed the presence in activated NK cells and mononuclear phagocytes of the fragments expected on the basis of the reported cDNAs. In addition, amplification with a common A/B- and an A-specific oligonucleotide yielded an unexpected, abundant, 1649-bp fragment. Sequence analysis as well as Northern blotting and RNase protection with different probes revealed that the CCR2 gene is expressed in activated NK cells and mononuclear phagocytes as a predominant long transcript (3.4 kb) consisting of CCR2B, followed by a novel sequence (X), corresponding to an intron in the genome, and by a CCR2A-specific portion. The predominant long transcript is polyadenylated and present in the cytoplasm. The augmented migratory capacity of IL-2 activated vs resting NK cells was associated with increased CCR2 transcript levels.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9058802

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  CD192 gene variant and susceptibility to cervical cancer: a meta analysis.

Authors:  Yuying Chen; Xinli Liu; Min Chen; Jian Shen; Yanqi Lu; Lei Yu; Shouying Liu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 2.  Immunogenomic Analysis of Exceptional Responder to ALT-803 (IL-15 Analogue) in BCG Unresponsive Nonmuscle Invasive Bladder Cancer: A Case Series and Review of the Literature.

Authors:  Jeffrey Huang; Stephen L Shiao; Hideki Furuya; Charles J Rosser
Journal:  J Immunother       Date:  2019 Nov/Dec       Impact factor: 4.456

3.  Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections.

Authors:  Mark S Wilson; Carl G Feng; Daniel L Barber; Felix Yarovinsky; Allen W Cheever; Alan Sher; Michael Grigg; Mary Collins; Lynette Fouser; Thomas A Wynn
Journal:  J Immunol       Date:  2010-03-10       Impact factor: 5.422

4.  Viral expression of CCL2 is sufficient to induce demyelination in RAG1-/- mice infected with a neurotropic coronavirus.

Authors:  Taeg S Kim; Stanley Perlman
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

5.  Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis.

Authors:  Brad E Morrison; Stacy J Park; Jill M Mooney; Borna Mehrad
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

6.  Induction of MCP-1 expression in airway epithelial cells: role of CCR2 receptor in airway epithelial injury.

Authors:  Matthew C Lundien; Kamal A Mohammed; Najmunnisa Nasreen; R S Tepper; Joyce A Hardwick; Kerry L Sanders; Robert D Van Horn; Veena B Antony
Journal:  J Clin Immunol       Date:  2002-05       Impact factor: 8.317

7.  HBD-3 induces NK cell activation, IFN-γ secretion and mDC dependent cytolytic function.

Authors:  Chelsey J Judge; Elane Reyes-Aviles; Sara J Conry; Scott S Sieg; Zhimin Feng; Aaron Weinberg; Donald D Anthony
Journal:  Cell Immunol       Date:  2015-06-30       Impact factor: 4.868

8.  CCR2 defines a distinct population of NK cells and mediates their migration during influenza virus infection in mice.

Authors:  Mary J G van Helden; Dietmar M W Zaiss; Alice J A M Sijts
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

Review 9.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

Review 10.  The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies.

Authors:  Tobias Bald; Matthew F Krummel; Mark J Smyth; Kevin C Barry
Journal:  Nat Immunol       Date:  2020-07-20       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.